Ginkgo bioworks sec filings

Author: vhgs

August undefined, 2024

WebApr 13, 2024 · About Ginkgo Bioworks. Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve … WebSubject Company: Ginkgo Bioworks, Inc. Commission File No.: 001-40097. What’s Happening?! TL;DR: ... Ginkgo will be a publicly traded company on the New York Stock …

EDGAR Filing Documents for 0001959173-23-000552

WebSep 7, 2024 · Key Features. Various SEC filing data available including balance sheets, cash flows and more. Central Index Key (CIK) and ticker conversions for looking up … WebApr 13, 2024 · Xponance Inc.’s holdings in Ginkgo Bioworks were worth $85,000 as of its most recent filing with the SEC. Other hedge funds and other institutional investors have … herculiner flag couch

Selecta Biosciences and Ginkgo Bioworks Announce New …

WebMar 1, 2024 · Ginkgo Bioworks Holdings, Inc. (DNA) SEC Filing 8-K Material Event for the period ending Wednesday, March 1, 2024. HOME; LOGIN; PREMIUM; FREE TRIAL; … WebJan 11, 2024 · Management to highlight updates today at the 41st Annual J.P. Morgan Healthcare Conference at 11:15 a.m. PT (2:15 p.m. ET) BOSTON, MA – January 11, 2024 – Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced today preliminary performance updates for the year ended … WebSep 27, 2024 · The Schedule 13D is being filed by Jason Kelly (the “Reporting Person”), a citizen of the United States. The business address of the Reporting Person is c/o Ginkgo Bioworks Holdings, Inc., 27 ... herculiner hcl1g8 gray brush-on bed liner kit

SEC Filings - SEC Filings Details - Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc. (DNA) SEC Filing S-1 IPO Report

WebAt Ginkgo Bioworks, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. At Ginkgo Bioworks, we promise to treat your data with respect and will not share … WebNov 14, 2024 · Ginkgo Bioworks Holdings, Inc. (DNA) SEC Filing 8-K Material Event for the period ending Monday, November 14, 2024 herculiner gray quartWebApr 14, 2024 · Moloney Securities Asset Management LLC’s holdings in Ginkgo Bioworks were worth $167,000 as of its most recent filing with the Securities and Exchange Commission. herculiner grey kit

"WebNov 18, 2024 · Ginkgo Bioworks Holdings, Inc. et al RSS Track this Docket Docket Report This docket was last retrieved on November 19, 2024. A more recent docket listing may be available from PACER . Access additional case information on PACER Use the links below to access additional information about this case on the US Court's PACER system. " - Ginkgo bioworks sec filings

Ginkgo bioworks sec filings

EDGAR Filing Documents for 0001959173-23-000552

WebFiling Detail. SEC Home » Search the Next-Generation EDGAR System » Company Search » Current Page; Form 144 - Report of proposed sale of securities: SEC Accession No. 0001959173-23-000552 Filing Date. 2024-04-12. Accepted. 2024-04-12 09:26:11. ... Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings) WebSep 7, 2024 · SEC Filings Ginkgo Bioworks Holdings, Inc. (DNA) S-1 IPO Report Wed Sep 07 2024 DNA Valuations Intrinsic Value Financial Stability Financial Ratios Insider Trades Manager Portfolios Notifications DNA Annual Reports 10-K Annual Report March 2024 DNA Quarterly Reports 10-Q Quarterly Report November 2024 10-Q Quarterly …

Did you know?

WebApr 12, 2024 · At Ginkgo Bioworks, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. WebFiling Detail. SEC Home » Search the Next-Generation EDGAR System » Company Search » Current Page; Form 144 - Report of proposed sale of securities: SEC Accession No. …

WebApr 12, 2024 · Ginkgo Bioworks Holdings, Inc. SEC Filing - Annual Report (10-K) March 13, 2024 SEC FilingsMon, Mar. 13 Payoneer, Unity Software, BILL among others to disclose exposure to Silicon Valley...

WebGinkgo Bioworks Holdings, Inc. 27 Drydock Avenue, 8 th Floor . Boston, MA 02210 . 877-422-5362. Copies of these filings are also available, without charge, on the SEC’s … Webat Ginkgo Bioworks. Quick reminder, during the presentation today, we'll be making forward-looking statements which involve risks and uncertainties, including about certain unaudited preliminary financial information. Please refer to our filings with the SEC to learn more about these risks and uncertainties.

WebAs Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/13/23 Ginkgo Bioworks Holdings, Inc. S-8 3/13/23 5:285K Donnelley … Solutions/FA Solutions/FA Registration …

WebNov 14, 2024 · Ginkgo Bioworks Holdings, Inc. (DNA) SEC Filing 8-K Material Event for the period ending Monday, November 14, 2024 matthew childs garden designWebApr 13, 2024 · Ginkgo Bioworks Holdings, Inc. has a 52-week low of $1.17 and a 52-week high of $4.91. The company has a 50-day simple moving average of $1.47 and a 200-day simple moving average of $1.94.... herculiner gallonWebApr 6, 2024 · SEC filings and transcripts for Ginkgo Bioworks Holdings Inc, including financials, news, proxies, indentures, prospectuses, and credit agreements Ginkgo … herculiner hcl1g8 gray 1 gallonWebGINKGO BIOWORKS HOLDINGS, INC. (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 37611X100 (CUSIP Number) September … herculiner greyWebApr 3, 2024 · Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF matthew chimientiWebginkgo bioworks, inc. 27 DRYDOCK AVENUE, 8TH FLOOR. BOSTON MA 02210. Business Phone: 877-422-5362. SEC SIC CODE: 2834-PHARMACEUTICAL … matthew chimeraWebOct 14, 2024 · Ginkgo Bioworks Holdings, Inc. Class A Common Stock . We intend to use the net proceeds of this offering to offset the cash used to finance the acquisition (the … matthew chimento